Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Actinium Pharmaceuticals (ATNM) Return on Assets (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Return on Assets for 7 consecutive years, with 0.56% as the latest value for Q4 2025.

  • Quarterly Return on Assets changed N/A to 0.56% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.56% through Dec 2025, changed N/A year-over-year, with the annual reading at 0.5% for FY2023, 15.0% down from the prior year.
  • Return on Assets for Q4 2025 was 0.56% at Actinium Pharmaceuticals, up from 0.66% in the prior quarter.
  • The five-year high for Return on Assets was 0.18% in Q2 2021, with the low at 0.69% in Q2 2025.
  • Average Return on Assets over 5 years is 0.44%, with a median of 0.48% recorded in 2023.
  • The sharpest move saw Return on Assets fell -29bps in 2023, then increased 7bps in 2024.
  • Over 5 years, Return on Assets stood at 0.3% in 2021, then grew by 3bps to 0.3% in 2022, then tumbled by -96bps to 0.58% in 2023, then increased by 18bps to 0.48% in 2024, then dropped by -18bps to 0.56% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.56%, 0.66%, and 0.69% for Q4 2025, Q3 2025, and Q2 2025 respectively.